King & Spalding’s False Claims Act (“FCA”) Practice includes over fifty lawyers dedicated full time to government investigations and False Claims Act litigation and dozens of other attorneys who focus significant portions of their practice on this area. This includes more than forty former federal prosecutors and other enforcement officials, as well as experienced litigators and regulatory counsel in industries frequently targeted by FCA suits, including: healthcare, pharmaceuticals, biotech, medical devices, defense and government contracts, construction litigation, energy, and financial/professional services.
Our Team contains numerous attorneys who have served in key positions within the U.S. Department of Justice, the U.S. Department of Defense, the U.S. Food and Drug Administration, and other regulatory enforcement agencies. They understand the investigative process because they themselves prosecuted cases in the Government, and in private practice have developed highly effective defenses for an array of clients. Notably, our practice includes:
- Christopher A. Wray. Former Assistant Attorney General in charge of the Justice Department’s Criminal Division.
- Gary G. Grindler. Former acting Deputy Attorney General of the Justice Department, the second highest office in the department, and Chief of Staff to the Attorney General.
- Jeffrey S. Bucholtz. Former acting Assistant Attorney General in charge of the Justice Department’s Civil Division, responsible for the Department’s FCA enforcement activities.
- Gary W. Eiland, Glen A. Reed, and Richard L. Shackelford. Past presidents of the American Health Lawyers Association, who collectively have decades of experience defending healthcare companies in government investigations.
- Eleanor J. Hill. Former Inspector General of the Department of Defense.
- Stephen S. Cowen, Paul B. Murphy, John C. Richter, and James K. Vines. Former United States Attorneys.
- Edward M. Basile, Mark S. Brown, Frederick H. Degnan, Michael Petty, and Elaine H. Tseng. Former members of the FDA’s Office of the Chief Counsel.
- Mark D. Polston. Former Deputy Associate General Counsel for Litigation in the Office of the General Counsel, Centers for Medicare and Medicaid Services (CMS) Division at the United States Department of Health and Human Services.
- Preeya N. Pinto. Former Deputy General Counsel, Principal Deputy General Counsel and Acting General Counsel of the United States Department of Health and Human Services (HHS).
The combination of King & Spalding’s deep “bench strength,” unparalleled litigation and regulatory expertise in the core industries subject to FCA exposure, and extensive experience investigating and litigating FCA matters at the trial and appellate level (both while inside the government and in private practice) is unique.
From high-profile criminal and civil fraud and abuse matters to private, internal corporate compliance and employment issues, we tailor our approach to each client and each set of facts. Whether the matter requires delicate interaction with or a voluntary disclosure to regulators or an aggressive litigation stance at trial or on appeal, our Team is prepared to vigorously defend our clients’ interests. As shown by our record of successfully representing corporations in this area, King & Spalding’s attorneys have the experience and backgrounds necessary to successfully guide businesses through these difficult and complex matters.